A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/12123332

Download in:

View as

General Info

PMID
12123332